7.41
price down icon6.68%   -0.53
after-market 시간 외 거래: 7.04 -0.37 -4.99%
loading

Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스

pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Apr 02, 2025
pulisher
Mar 30, 2025

Swiss National Bank Takes $1.22 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Proficio Capital Partners LLC Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Adaptive Biotechnologies Corp: Analyzing ADPT Stock Trends - investchronicle.com

Mar 28, 2025
pulisher
Mar 28, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 12-Month HighShould You Buy? - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Adaptive Biotechnologies’ chief scientific officer sells shares for $15,282 By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 26, 2025

Adaptive Biotechnologies’ chief scientific officer sells shares for $15,282 - Investing.com India

Mar 26, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Acquires 39,831 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Adaptive Biotechnologies stock hits 52-week high at $8.95 By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Adaptive Biotechnologies stock hits 52-week high at $8.95 - Investing.com

Mar 24, 2025
pulisher
Mar 23, 2025

Amundi Boosts Stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Upgraded by The Goldman Sachs Group - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up – What’s Next? - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Has $2.18 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Adaptive Biotechnologies Gains Following Goldman Sachs Upgrade, Share Climb 6% Near Friday Close - MarketScreener

Mar 21, 2025
pulisher
Mar 21, 2025

Analyst Expectations For Adaptive Biotechnologies's Future - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8 - Marketscreener.com

Mar 21, 2025
pulisher
Mar 21, 2025

Goldman Sachs Upgrades Adaptive Biotechnologies (ADPT) - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March - Insider Monkey

Mar 20, 2025
pulisher
Mar 17, 2025

10 Stocks Insiders Are Selling In March - Insider Monkey

Mar 17, 2025
pulisher
Mar 14, 2025

Proficio Capital Partners LLC Takes $93,000 Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Critical Survey: Adaptive Biotechnologies (NASDAQ:ADPT) vs. Beam Therapeutics (NASDAQ:BEAM) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies director sells shares worth $70,500 By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies director sells shares worth $70,500 - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies director sells shares worth $402,270 - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies Executives Sell Shares - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Minimal Residual Disease Market Expected to rise, 2032 | Adaptive Biotechnologies, Bristol-Myers Squibb Company, Natera, Kite Pharma, Amgen Inc., expected to boost the market - Barchart

Mar 12, 2025
pulisher
Mar 11, 2025

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

US Bancorp DE Sells 43,819 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

Insider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT) CEO Sells $819,109.98 in Stock - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 6.5% on Insider Selling - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Adaptive Biotechnologies director sells $124,372 in stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Adaptive Biotechnologies CEO Chad Robins sells $1.6 million in stock By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 07, 2025

Adaptive Biotechnologies’ chief commercial officer Sharon Benzeno sells $311,792 in stock By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Principal Financial Group Inc. Purchases Shares of 143,444 Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies president Julie Rubinstein sells $415,539 in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies CFO sells shares worth $72,072 By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies’ chief scientific officer sells $675k in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies chief people officer sells $145,845 in stock - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies chief people officer sells $145,845 in stock By Investing.com - Investing.com Australia

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies director sells $124,372 in stock - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies president Julie Rubinstein sells $415,539 in stock - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies’ chief scientific officer sells $675k in stock - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies’ chief commercial officer Sharon Benzeno sells $311,792 in stock - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Private Advisor Group LLC Makes New $264,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Holdings Increased by Rhumbline Advisers - Defense World

Mar 06, 2025
pulisher
Feb 26, 2025

D.A. Davidson & CO. Buys 6,725 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Feb 26, 2025
pulisher
Feb 23, 2025

Adaptive Biotechnologies’ (ADPT) “Overweight” Rating Reiterated at Piper Sandler - Defense World

Feb 23, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
자본화:     |  볼륨(24시간):